GlassScriptPhysician profile
Breck M Tiernan
NPI 1861614380
$965.50
in general payments reported to CMS, 2019-2025
17 companies · $28.25 in 2025
The $28.25 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $129 · 2021: $159 · 2022: $290 · 2023: $76.71 · 2024: $116 · 2025: $28.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $369.98 | 2019-2024 | Grafix, Stravix, Oasis |
| Organogenesis INC. | $162.48 | 2019-2022 | |
| Stryker Corporation | $108.00 | 2019-2022 | |
| Dynasplint Systems INC. | $44.27 | 2022-2023 | Dynasplint |
| Abbott Laboratories | $35.02 | 2019-2022 | |
| Horizon Therapeutics Plc | $34.10 | 2019-2020 | |
| Misonix INC | $31.81 | 2021 | |
| Averitas Pharma INC. | $28.25 | 2025 | Qutenza |
| Next Science LLC | $28.05 | 2023 | Surgx, Xperience, Blastx |
| Kerecis Limited | $20.46 | 2020 | |
| Paratek Pharmaceuticals, INC. | $18.37 | 2022 | |
| Alfasigma USA, INC. | $17.10 | 2020 | |
| Orthofix Medical, INC. | $16.74 | 2022 | |
| Baudax Bio INC. | $14.53 | 2021 | |
| Osiris Therapeutics INC. | $14.26 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.08 | 2019 | |
| Celularity INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breck Tiernan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.